Gainers
- Rail Vision Ltd. (NASDAQ:RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday.
- Sharps Technology, Inc. (NASDAQ:STSS) rose 31.4% to $1.6815 after climbing around 6% on Tuesday.
- TransMedics Group, Inc. (NASDAQ:TMDX) gained 29.3% to $28.28 after better than expected Q1 earnings and 2022 guidance.
- Super Micro Computer, Inc. (NASDAQ:SMCI) surged 27.9% to $55.28 after the company reported better-than-expected Q3 EPS and sales results and raised Q4 guidance.
- Livent Corporation (NYSE:LTHM) rose 25.6% to $27.53 after the company reported better-than-expected Q1 results and raised FY22 guidance.
- Aclarion, Inc. (NASDAQ:ACON) rose 22.7% to $2.1102 after declining over 5% on Tuesday. The company had its IPO on April 22.
- CarParts.com, Inc. (NASDAQ:PRTS) shares jumped 22.4% to $8.31 after the company reported better-than-expected Q1 EPS and sales results.
- Superior Industries International, Inc. (NYSE:SUP) shares gained 22.2% to $3.92 following better-than-expected Q1 results.
- eHealth, Inc. (NASDAQ:EHTH) gained 20.3% to $9.97 after the company reported better-than-expected Q1 sales results.
- Kimball International, Inc. (NASDAQ:KBAL) surged 19.4% to $9.14 after the company reported better-than-expected Q3 sales results and adjusted EPS results were higher year over year.
- BlueLinx Holdings Inc. (NYSE:BXC) gained 17% to $89.58 after the company reported better-than-expected Q1 EPS and sales results and increased its share buyback to $100 million.
- Brickell Biotech, Inc. (NASDAQ:BBI) rose 16.7% to $0.2712 after the company announced the sale of sofpironium bromide to Botanix Pharmaceuticals for $9 million in upfront and potential near-term regulatory milestone payments. The company is also eligible to receive additional success-based regulatory and sales milestone payments of up to $168 million.
- Powell Industries, Inc. (NASDAQ:POWL) gained 15.5% to $22.89 after the company reported better-than-expected Q2 EPS and sales results.
- Alaunos Therapeutics, Inc. (NASDAQ:TCRT) rose 14.5% to $0.6353 after jumping around 13% on Tuesday.
- Vivint Smart Home, Inc. (NYSE:VVNT) gained 14.2% to $6.18 after the company reported better-than-expected Q1 sales results and reaffirmed FY22 sales guidance.
- Global Industrial Company (NYSE:GIC) jumped 13.9% to $34.69 following strong Q1 earnings.
- Chegg, Inc. (NYSE:CHGG) gained 13.2% to $19.71 as the stock rebounded after falling following its Q1 earnings report.
- Summit Midstream Partners, LP (NYSE:SMLP) gained 13.2% to $19.95 following Q1 results.
- W&T Offshore, Inc. (NYSE:WTI) jumped 12.9% to $5.59 after the company reported better-than-expected Q1 EPS and sales results.
- A10 Networks, Inc. (NYSE:ATEN) gained 12.1% to $16.45 after the company reported better-than-expected Q1 adjusted EPS and sales results.
- Generac Holdings Inc. (NYSE:GNRC) jumped 9.6% to $256.84 after the company reported better-than-expected Q1 EPS and sales results. The company also raised its FY22 sales growth guidance.
- The Scotts Miracle-Gro Company (NYSE:SMG) rose 7.5% to $113.91. Scotts Miracle-Gro announced record second-quarter sales in its U.S. consumer segment driven by continued support from its major retail partners.
- Starbucks Corporation (NASDAQ:SBUX) rose 7.5% to $79.96 as the company reported second-quarter revenue of $7.64 billion, which was up 15% year-over-year. The quarterly revenue was a second-quarter record for the company and came in ahead of a consensus estimate of $7.6 billion.
Losers
- Amarin Corporation plc (NASDAQ:AMRN) shares dipped 43.3% to $1.5550 after it said it would continue suspending 2022 revenue guidance and Q1 earnings came short of expectations. The company reported Q1 sales of $94.6 million, down 33% Y/Y, missing the consensus of $128.37 million.
- Kezar Life Sciences, Inc. (NASDAQ:KZR) fell 39% to $7.51 after the company reported topline results from the PRESIDIO Phase 2 trial of zetomipzomib (KZR-616) in patients with dermatomyositis (DM) and polymyositis (PM), chronic inflammatory diseases of muscle.
- Tupperware Brands Corporation (NYSE:TUP) dropped 33.8% to $11.86 after the company reported worse-than-expected Q1 results and withdrew its FY22 guidance.
- Lyft, Inc. (NASDAQ:LYFT) fell 32.5% to $20.76 after the company reported Q1 earnings results and issued Q2 sales guidance below analyst estimates.
- The Andersons, Inc. (NASDAQ:ANDE) dropped 30.6% to $36.20 after the company reported Q1 earnings results.
- Blue Water Vaccines, Inc. (NASDAQ:BWV) fell 28.9% to $4.5886. Blue Water Vaccines S-1 showed registration for 2.4 million share common stock offering via selling shareholders.
- IAMGOLD Corporation (NYSE:IAG) dipped 26% to $2.0650 following Q1 results. The company also named Maryse Bélanger as Interim President and CEO.
- Clovis Oncology, Inc. (NASDAQ:CLVS) declined 24.2% to $1.59 after the company reported worse-than-expected Q1 EPS and sales results.
- Harvard Bioscience, Inc. (NASDAQ:HBIO) dipped 24.1% to $4.2845 after the company reported Q1 earnings results.
- Blucora, Inc. (NASDAQ:BCOR) dipped 21.3% to $16.34 after the company reported worse-than-expected Q1 EPS and sales results and issued FY22 adjusted EPS and sales guidance below estimates.
- Revolve Group, Inc. (NYSE:RVLV) fell 21% to $34.35 after the company reported Q1 earnings results.
- XORTX Therapeutics Inc. (NASDAQ:XRTX) fell 19.4% to $1.4750. XORTX Therapeutics shares jumped 59% on Tuesday after the company announced that dosing of human subjects has been initiated in the XRX-OXY-101 bridging pharmacokinetics study.
- Quad/Graphics, Inc. (NYSE:QUAD) dipped 19.2% to $5.05 following Q1 results.
- MacroGenics, Inc. (NASDAQ:MGNX) dropped 19% to $6.28 following Q1 results.
- Cardiovascular Systems, Inc. (NASDAQ:CSII) fell 18.9% to $16.32 after reporting weak quarterly sales.
- Infinera Corporation (NASDAQ:INFN) dropped 18.4% to $6.43 after the company reported worse-than-expected Q1 adjusted EPS and sales results and issued Q2 sales guidance below analyst estimates.
- Brinker International, Inc. (NYSE:EAT) fell 17.1% to $32.70 after the company reported worse-than-expected Q1 EPS and sales results. The company also issued FY22 EPS guidance below analyst estimates.
- Kymera Therapeutics, Inc. (NASDAQ:KYMR) dropped 15.5% to $21.01. Kymera Therapeutics reported worse-than-expected Q1 EPS and sales results.
- Conduent Incorporated (NASDAQ:CNDT) fell 15.5% to $4.58 following Q1 results.
- LL Flooring Holdings, Inc. (NYSE:LL) fell 14.4% to $12.76 after the company reported worse-than-expected Q1 EPS and sales results.
- LSB Industries, Inc. (NYSE:LXU) slipped 14% to $19.62 after the company reported worse-than-expected Q1 results.
- Red Rock Resorts, Inc. (NASDAQ:RRR) fell 13% to $39.10 following weak quarterly sales.
- Johnson Controls International plc (NYSE:JCI) dropped 12.4% to $54.21 after the company cut its FY22 EPS guidance below analyst estimates.
- Akamai Technologies, Inc. (NASDAQ:AKAM) fell 10.2% to $102.14 after the company reported worse-than-expected Q1 results.
- Skyworks Solutions, Inc. (NASDAQ:SWKS) dipped 9.9% to $107.68 following Q2 results.
- Herbalife Nutrition Ltd. (NYSE:HLF) shares fell 9.3% to $25.00 after the company reported a decline in Q1 EPS results.
- Ouster, Inc. (NYSE:OUST) fell 6.8% to $3.2350 after the company reported worse-than-expected Q1 results.
